Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1894335Generated: November 2, 2026

1-[2-(2-Hydroxyethoxy)ethyl]piperazine → HCID 25227417, compound

https://huagongshe.com/reaction/1894335

Reaction equation

Participants

RoleNameHCIDCharge
Reactant1-[2-(2-Hydroxyethoxy)ethyl]piperazineHCID 139436—
Reactantrac-(4S*,5R*)-2-(2-tert-butyl-4-ethoxy-pyrimidin-5-yl)-4,5-bis-(4-chloro-phenyl)-4,5-dimethyl-4,5-dihydro-imidazole-1-carbonyl chlorideHCID 76588520—
ProductHCID 25227417HCID 25227417—

Reaction Steps

In a manner analogous to the method described in example 3, rac-(4S*,5R*)-2-(2-tert-butyl-4-ethoxy-pyrimidin-5-yl)-4,5-bis-(4-chloro-phenyl)-4,5-dimethyl-4,5-dihydro-imidazole-1-carbonyl chloride was reacted with 1-[2-(2-hydroxyethoxy)-ethyl]-piperazine (Aldrich) to give the title compound as a racemic mixture. The enantiomers were then separated by supercritical fluid chromatography (Berger Instrument Multi-Gram II, Daicel ChiralPak OD-H 3×25 cm, 35° C. at 100 bar, eluting with 30% methanol in carbon dioxide). HR-MS (ES, m/z) calculated for C36H46N6O4Cl2 [(M+H)+] 697.3031, observed 697.3026.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08513239B2
Source datasetuspto-grants-2013_08
ORD IDord-2e0c5b9daa0146c4baa6413fcdba36f8
Source noteuspto-grants-2013_08